LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

Search

iRhythm Technologies Inc

Затворен

СекторЗдравеопазване

182.88 0.64

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

177.42

Максимум

187.6

Ключови измерители

By Trading Economics

Приходи

9M

-5.2M

Продажби

6.2M

193M

Марж на печалбата

-2.702

Служители

2,000

EBITDA

7.7M

2.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+20.6% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

33M

5.9B

Предишно отваряне

182.24

Предишно затваряне

182.88

Настроения в новините

By Acuity

34%

66%

86 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.12.2025 г., 17:29 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2.12.2025 г., 16:21 ч. UTC

Печалби

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2.12.2025 г., 16:18 ч. UTC

Печалби

Correction to Scotiabank Quarterly Earnings Buoyed Article

2.12.2025 г., 23:53 ч. UTC

Пазарно говорене

Nikkei May Rise After Gains on Wall Street -- Market Talk

2.12.2025 г., 22:48 ч. UTC

Печалби

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2.12.2025 г., 22:12 ч. UTC

Пазарно говорене

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2.12.2025 г., 22:03 ч. UTC

Пазарно говорене

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2.12.2025 г., 21:56 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 21:44 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:38 ч. UTC

Пазарно говорене

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2.12.2025 г., 21:19 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 20:06 ч. UTC

Пазарно говорене

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2.12.2025 г., 19:55 ч. UTC

Пазарно говорене

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене
Печалби

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2.12.2025 г., 19:24 ч. UTC

Пазарно говорене

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2.12.2025 г., 19:06 ч. UTC

Пазарно говорене

Precious Metals Step Back After Silver Sets Record -- Market Talk

2.12.2025 г., 18:27 ч. UTC

Придобивния, сливания и поглъщания

Kraken to Acquire Backed Finance AG

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 15:17 ч. UTC

Пазарно говорене

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2.12.2025 г., 14:47 ч. UTC

Пазарно говорене

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2.12.2025 г., 14:38 ч. UTC

Пазарно говорене

Silver Steps Back From Record Levels -- Market Talk

2.12.2025 г., 14:31 ч. UTC

Пазарно говорене
Печалби

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

20.6% нагоре

12-месечна прогноза

Среден 220.38 USD  20.6%

Висок 244 USD

Нисък 185 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

12

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

104.78 / 137.91Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

86 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat